Clinical trial
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
NCT03313011 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2017
- Completion date
- July 31, 2027
- Enrollment
- 47 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
apraxia of speech, non-fluent aphasia, primary progressive aphasia, primary progressive nonfluent aphasia